These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11122567)

  • 21. Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial.
    Valgimigli M; Campo G; Percoco G; Bolognese L; Vassanelli C; Colangelo S; de Cesare N; Rodriguez AE; Ferrario M; Moreno R; Piva T; Sheiban I; Pasquetto G; Prati F; Nazzaro MS; Parrinello G; Ferrari R;
    JAMA; 2008 Apr; 299(15):1788-99. PubMed ID: 18375998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.
    Topol EJ; Moliterno DJ; Herrmann HC; Powers ER; Grines CL; Cohen DJ; Cohen EA; Bertrand M; Neumann FJ; Stone GW; DiBattiste PM; Demopoulos L;
    N Engl J Med; 2001 Jun; 344(25):1888-94. PubMed ID: 11419425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycoprotein IIb/IIIa inhibition.
    Horton H
    JAMA; 2004 Nov; 292(18):2211; author reply 2211-2. PubMed ID: 15536102
    [No Abstract]   [Full Text] [Related]  

  • 24. The TARGET trial: hit or miss?
    Moliterno DJ; Topol EJ
    Eur Heart J; 2002 Jun; 23(11):835-7. PubMed ID: 12042001
    [No Abstract]   [Full Text] [Related]  

  • 25. Drawbacks of nonrandomized trials in acute coronary syndromes.
    Biondi-Zoccai GG; Abbate A; Agostoni P; Valgimigli M; Sangiorgi GM
    Am J Cardiol; 2006 Jan; 97(1):151. PubMed ID: 16377303
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment with a GPIIb/IIIa antagonist inhibits thrombin generation in platelet rich plasma from patients.
    Keularts IM; Béguin S; de Zwaan C; Hemker HC
    Thromb Haemost; 1998 Sep; 80(3):370-1. PubMed ID: 9759611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes.
    Braunwald E; Maseri A; Armstrong PW; Califf RM; Gibler WB; Hamm CW; Simoons ML; Van de Werf F
    Eur Heart J; 1998 Apr; 19 Suppl D():D22-30. PubMed ID: 9597519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of platelet glycoprotein IIb/IIIa receptor blockade with tirofiban on adverse cardiac events in women with unstable angina/non-ST-elevation myocardial infarction (PRISM-PLUS Study).
    Huynh T; Theroux P; Snapinn S; Wan Y;
    Am Heart J; 2003 Oct; 146(4):668-73. PubMed ID: 14564321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early discharge is feasible following primary percutaneous coronary intervention with transradial stent implantation under platelet glycoprotein IIb/IIIa receptor blockade. Results of the AGGRASTENT Trial.
    Dirksen MT; Ronner E; Laarman GJ; van Heerebeek L; Slagboom T; van der Wieken LR; van der Wouw PA; Kiemeneij F
    J Invasive Cardiol; 2005 Oct; 17(10):512-7. PubMed ID: 16204742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Net clinical benefit of prehospital glycoprotein IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction and high risk of bleeding: effect of tirofiban in patients at high risk of bleeding using CRUSADE bleeding score.
    Hermanides RS; Ottervanger JP; ten Berg JM; Gosselink AT; van Houwelingen G; Dambrink JH; Stella PR; Hamm C; van 't Hof AW;
    J Invasive Cardiol; 2012 Mar; 24(3):84-9. PubMed ID: 22388296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Unstable coronary artery diseases: risk categorization and treatment strategies].
    Qian X
    Zhonghua Nei Ke Za Zhi; 2001 May; 40(5):293-5. PubMed ID: 12947968
    [No Abstract]   [Full Text] [Related]  

  • 32. Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial.
    Valgimigli M; Percoco G; Malagutti P; Campo G; Ferrari F; Barbieri D; Cicchitelli G; McFadden EP; Merlini F; Ansani L; Guardigli G; Bettini A; Parrinello G; Boersma E; Ferrari R;
    JAMA; 2005 May; 293(17):2109-17. PubMed ID: 15870414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global impairment of coronary blood flow in the setting of acute coronary syndromes (a RESTORE substudy). Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis.
    Gibson CM; Goel M; Murphy SA; Dotani I; Marble SJ; Deckelbaum LI; Dodge JT; King SB;
    Am J Cardiol; 2000 Dec; 86(12):1375-7, A5. PubMed ID: 11113417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upstream glycoprotein IIb/IIIa inhibitors for STEMI: use on-time or not at all?
    Seto A; Kern MJ
    Catheter Cardiovasc Interv; 2012 May; 79(6):965-6. PubMed ID: 22511381
    [No Abstract]   [Full Text] [Related]  

  • 35. Tirofiban counteracts pending myocardial infarction.
    Rasmanis G; Sylvén C
    J Intern Med; 2000 Oct; 248(4):349-52. PubMed ID: 11086647
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes.
    Perez de Arenaza D; Bakhai A; Flather M
    N Engl J Med; 2001 Nov; 345(21):1573; author reply 1574-5. PubMed ID: 11794229
    [No Abstract]   [Full Text] [Related]  

  • 37. Atorvastatin for reduction of myocardial damage during angioplasty trials.
    Nusca A; Melfi R; Patti G; Di Sciascio G
    J Cardiovasc Med (Hagerstown); 2010 Oct; 11(10):709-11. PubMed ID: 20815110
    [No Abstract]   [Full Text] [Related]  

  • 38. Pasta without sauce?
    Denktas AE; Smalling RW
    Catheter Cardiovasc Interv; 1999 Nov; 48(3):269-70. PubMed ID: 10525225
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical evidence for critical cardiac care.
    Torpy JM
    JAMA; 2002 Apr; 287(13):1638-9. PubMed ID: 11926875
    [No Abstract]   [Full Text] [Related]  

  • 40. Reperfusion for acute myocardial infarction: is the future in plastics?
    Rao SV; Jollis JG
    Mayo Clin Proc; 2000 Oct; 75(10):991-3. PubMed ID: 11040845
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.